InvestorsHub Logo
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Re: None

Thursday, 12/15/2022 7:09:36 AM

Thursday, December 15, 2022 7:09:36 AM

Post# of 640572
MDWD $1.28 --FDA Decision in 2 Weeks ..Cheap and well financed biotech with huge upside

Market Cap $52 million / Cash Balance $34.5 million additional 7.5 million milestone payment expected upon FDA approval



NexoBrid PDUFA date of January 1, 2023; Upon approval, NexoBrid expected to generate meaningful revenues

Company focused on the billion-dollar market opportunity with EscharEx Phase 3 clinical study to begin in first-half 2023

$30.5 million in gross proceeds raised; operating cash runway through 2025



Presentation
https://ir.mediwound.com/static-files/0ea1057e-b20d-4acf-914a-e5e344982438

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.